Cargando…
Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
BACKGROUND: The pace of novel medical treatments and approaches to therapy has accelerated in recent years. Unfortunately, many potential therapeutic advances do not fulfil their promise when subjected to randomized controlled trials. It is therefore highly desirable to speed up the process of evalu...
Autores principales: | Royston, Patrick, Barthel, Friederike M-S, Parmar, Mahesh KB, Choodari-Oskooei, Babak, Isham, Valerie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078872/ https://www.ncbi.nlm.nih.gov/pubmed/21418571 http://dx.doi.org/10.1186/1745-6215-12-81 |
Ejemplares similares
-
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013) -
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013) -
A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011) -
The extension of total gain (TG) statistic in survival models: properties and applications
por: Choodari-Oskooei, Babak, et al.
Publicado: (2015) -
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)